Applied DNA Expands Internationally with New Central DNA Testing Laboratory in India
January 23 2018 - 5:30AM
Business Wire
New Facility to Service Growing Business in
Textiles, Global Supply Chains from the Asia Pacific Region
Applied DNA Sciences, Inc. (NASDAQ:APDN, “Applied DNA,” “the
Company”) today announced the establishment of a Central DNA
Testing Laboratory in Ahmedabad, India providing full forensic
authentication services. The laboratory supports Applied DNA’s
growing global textile business in the Asia-Pacific region with
expansion capability for other supply chains present in the region,
such as fertilizer and pharmaceuticals. Officially opening on
February 15, 2018, the Central Laboratory is strategically located
in the state of Gujarat, an economic hub for the development and
advancement of cotton, other textiles, fertilizers, petrochemicals
and pharmaceuticals.
Dr. Ila Lansky, a forensic scientist with over 11 years of
forensic DNA experience, will direct the Central DNA Testing
Laboratory. She currently oversees all aspects of forensic
analysis, testing, authentication and reporting for all samples
submitted, following the standard operating procedures established
by Applied DNA’s New York forensic laboratories. The Central DNA
Testing Laboratory is a high throughput laboratory, providing
customers with accurate reports in a short turnaround time.
“This is an important opportunity for Applied DNA to bring our
proven technologies to the heart of India’s textile industry, and
share our impeccable standards and operational protocols,” said Dr.
Lansky. “The laboratory will have the ability to process thousands
of samples, serving our textiles customers in the region.”
The Indian textile industry is currently estimated at
approximately $135 billion USD and is expected to reach $230
billion by 2023 (IBEF 2017). It is home to such global textile
brands and manufacturers as The Himatsingka Group and GHCL Limited.
Additionally, India is home to the sixth largest pharmaceutical
market in the world, with an expected value of $550 billion by 2020
(IBEF 2017).
“Opening a lab in Gujarat has both strategic and practical
importance for Applied DNA,” said Dr. James A. Hayward, president
and chief executive officer of Applied DNA. “Our partnership with
Himatsingka has proven remarkably successful, with uptake in the
commercial ecosystem and endorsement by big box retailers. Adoption
of our technologies by other textile companies is growing. Working
closely with such India-based industry majors as Himatsingka and
GHCL, we know Applied DNA’s value in enabling source-verified
supplied chains and contributing the steady growth and ensured
protection of the circular economy. It only makes sense for Applied
DNA to have a facility where so many of our current and future
partners are based.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and DNA mass production for
diagnostics and therapeutics. The Company makes life real and safe
by providing innovative, molecular-based technology solutions and
services that can help protect products, brands, entire supply
chains, and intellectual property of companies, governments and
consumers from theft, counterfeiting, fraud and diversion.
The proprietary DNA-based CertainT® platform can be used to
identify, tag, test, and track products, to help assure
authenticity, origin, traceability, sustainability and quality of
products. SigNature® DNA describes the core technology ingredient
that is at the heart of a family of uncopyable, security and
authentication solutions such as SigNature®T and fiberTyping®,
targeted towards textiles and apparel, BackTrac® and DNAnet®, for
anti-theft and loss prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can
be used to prosecute perpetrators. Applied DNA Sciences is also
engaged in the large-scale production of specific DNA sequences
using the polymerase chain reaction.
Visit adnas.com for more information. Follow us
on Twitter and LinkedIn. Join our mailing
list.
Forward-Looking Statements
The statements made by APDN in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe APDN’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
APDN. Actual results could differ materially from those projected
due to our short operating history, limited financial resources,
limited market acceptance, market competition and various other
factors detailed from time to time in APDN’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
28, 2017, which is available at www.sec.gov. APDN undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date
hereof to reflect the occurrence of unanticipated events, unless
otherwise required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180123005178/en/
Applied DNA SciencesInvestors:Sanjay M. Hurry,
212-838-3777shurry@lhai.comorMedia:Angie Mathews,
781-639-4924angie@cgprpublicrelations.comorProgram:MeiLin
Wan,
631-240-8849meilin.wan@adnas.comorweb: www.adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024